The Association for Molecular Pathology (AMP) announced the appointment of Lauren S. Menser, CAE, as its Chief Executive Officer, effective January 3, 2024. Menser will succeed Mary Steele Williams, MNA, MT(ASCP)SM, CAE, after her retirement. AMP’s national search for a new executive leader was administered by an outside consulting firm and overseen by a diverse group of member volunteers.
Menser has served AMP in various capacities for more than 17 years. Since 2016, she has served as Director of Strategic Development, acting as the primary architect of AMP’s alliance, collaboration, and partnership development programs. During her tenure, Menser substantially increased and diversified revenue in her direct areas of responsibility, played a pivotal role in the successful launch of AMP’s international events program, and created the AMP Corporate Advisory Council.
Menser is an accomplished senior executive with more than 20 years of experience in scientific association leadership. At AMP, she currently manages the Membership and Marketing & Communications teams, in addition to numerous contractors and consultants. Her certification, Certified Association Executive (CAE), from the American Society of Association Executives, is a marker of her broad knowledge and commitment to continuing education. A longtime champion of Diversity, Equity & Inclusion (DEI) efforts, Menser earned a DEI in the Workplace certificate from the University of South Florida in May 2021, and is a team lead in the design and continuing execution of AMP’s robust DEI Action Plan.